- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cancer of Colon in Japan
Total 1400 results
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedSmall Cell Lung CancerJapan
-
Wakayama Medical UniversityCompleted
-
NobelpharmaCompletedPlaque | Tuberous Sclerosis | Angiofibroma | Hypomelanotic MaculeJapan
-
Novartis PharmaceuticalsCompleted
-
Kyoto Prefectural University of MedicineActive, not recruiting
-
Novartis PharmaceuticalsCompletedCancer | Advanced Solid TumorJapan
-
Nihon Pharmaceutical Co., LtdCompletedGuillain-Barré SyndromeJapan
-
Kyoto Breast Cancer Research NetworkTerminated
-
Tokyo Women's Medical UniversityCompletedKidney Cancer | Metastatic CancerJapan
-
Kansai Hepatobiliary Oncology GroupCompletedBiliary Tract CancerJapan
-
Kansai Hepatobiliary Oncology GroupCompletedBiliary Tract CancerJapan
-
Kansai Hepatobiliary Oncology GroupCompleted
-
Kyoto Breast Cancer Research NetworkPfizerCompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleTaiwan, Japan, Korea, Republic of, Australia, Hong Kong
-
West Japan Thoracic Oncology GroupUnknown
-
Astellas Pharma Global Development, Inc.RecruitingGastric Cancer | Pharmacokinetics of Zolbetuximab | Gastro-esophageal Junction (GEJ) Cancer | Pharmacokinetics of Oxaliplatin | Pharmacokinetics of Fluorouracil Bolus (5-FU)United States, Japan, Italy, Korea, Republic of, Taiwan, France
-
Kindai UniversityJanssen Pharmaceutical K.K.RecruitingMetastatic Castration-sensitive Prostate CancerJapan
-
Comprehensive Support Project for Oncology ResearchCompleted
-
Wakayama Medical UniversityCompleted
-
Nihon Pharmaceutical Co., LtdCompleted
-
Tokyo Metropolitan Oncology GroupUnknown
-
BayerRecruitingMetastatic Hormone-sensitive Prostate Cancer (mHSPC)Japan
-
Kurume UniversityUnknownEffects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic ComplicationsJapan
-
Tokyo UniversityCompletedGastric CancerJapan
-
TakedaCompleted
-
Translational Research Center for Medical Innovation...Jikei University School of MedicineCompleted
-
Kansai Hepatobiliary Oncology GroupUnknownBiliary Tract CancerJapan
-
Kansai Hepatobiliary Oncology GroupCompleted
-
AmgenCompletedGastric or Gastroesophageal CancerJapan
-
Chugai PharmaceuticalCompleted
-
GlaxoSmithKlineCompleted
-
Kyushu UniversityRecruitingGastric Cancer | Pancreatic CancerJapan
-
Novartis PharmaceuticalsTerminatedCancer | Solid Tumor | Advanced Solid TumorJapan
-
Fukushima Medical UniversityKanagawa Cancer CenterUnknown
-
Wakayama Medical UniversityCompleted
-
Japanese Foundation for Cancer ResearchHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
Nihon Pharmaceutical Co., LtdCompleted
-
Okayama UniversityMerck Sharp & Dohme LLCRecruitingBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | BRCA1 Mutation | BRCA2 Mutation | BRCA Mutation | BRCA-Associated Breast CarcinomaJapan
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerJapan
-
Japan Breast Cancer Research GroupEisai Co., Ltd.Recruiting
-
Japanese Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerJapan
-
Nihon UniversityCompleted
-
Sumitomo Pharma Co., Ltd.CompletedMetastatic Colorectal CancerJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
AbbVieCompletedAdvanced Solid Tumors CancerJapan
-
Osaka UniversityRecruiting
-
Osaka UniversityRecruitingThyroid CancerJapan
-
Shizuoka Cancer CenterUnknown
-
Kochi UniversityCompleted